Back
Arrowhead Pharmaceuticals Stock Price Chart
The AI Energy Miracle
Details Here.
Sell
15
ARWR
Arrowhead Pharmaceuticals
Last Price:
$19.46
Seasonality Move:
23.49%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARWR is experiencing slight selling pressure.
Arrowhead Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.34 | Sell |
| 20-day SMA: | 22.49 | Sell |
| 50-day SMA: | 21.1 | Sell |
| 200-day SMA: | 23.71 | Sell |
| 8-day EMA: | 21.07 | Sell |
| 20-day EMA: | 21.7 | Sell |
| 50-day EMA: | 21.53 | Sell |
| 200-day EMA: | 23.77 | Sell |
Arrowhead Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 39.36 | Sell |
| Chaikin Money Flow: | -1728338 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.09 - 24.35) | Sell |
| Bollinger Bands (100): | (19.24 - 23.9) | Sell |
Arrowhead Pharmaceuticals Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arrowhead Pharmaceuticals Stock
Is Arrowhead Pharmaceuticals Stock a Buy?
-
Arrowhead Pharmaceuticals share price is 19.47 while ARWR 8-day simple moving average is 21.34, which is a Sell signal.
-
The stock price of ARWR is 19.47 while Arrowhead Pharmaceuticals 20-day SMA is 22.49, which makes it a Sell.
-
Arrowhead Pharmaceuticals 50-day simple moving average is 21.10 while ARWR share price is 19.47, making it a Sell technically.
-
ARWR stock price is 19.47 and Arrowhead Pharmaceuticals 200-day simple moving average is 23.71, creating a Sell signal.
ARWR Technical Analysis vs Fundamental Analysis
Sell
15
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy or a Sell?
-
Arrowhead Pharmaceuticals stock is rated a SellThe current Arrowhead Pharmaceuticals [ARWR] share price is $19.47. The Score for ARWR is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
Arrowhead Pharmaceuticals Stock Info
Market Cap:
2.4B
Price in USD:
19.47
Share Volume:
3.9M
Arrowhead Pharmaceuticals 52-Week Range
52-Week High:
39.83
52-Week Low:
17.05
Sell
15
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Arrowhead Pharmaceuticals Share Price Forecast
-
What is the Arrowhead Pharmaceuticals stock price today?The Arrowhead Pharmaceuticals stock price is 19.47 USD today.
-
Will ARWR stock go up or go down?Arrowhead Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Arrowhead Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arrowhead Pharmaceuticals is overvalued.
Is Arrowhead Pharmaceuticals Stock a Buy?
-
Arrowhead Pharmaceuticals share price is 19.47 while ARWR 8-day exponential moving average is 21.07, which is a Sell signal.
-
The stock price of ARWR is 19.47 while Arrowhead Pharmaceuticals 20-day EMA is 21.70, which makes it a Sell.
-
Arrowhead Pharmaceuticals 50-day exponential moving average is 21.53 while ARWR share price is 19.47, making it a Sell technically.
-
ARWR stock price is 19.47 and Arrowhead Pharmaceuticals 200-day simple moving average is 23.77, creating a Sell signal.
Fundamental Analysis of Arrowhead Pharmaceuticals
Is Arrowhead Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.11 per share, and an increase next year of $1.21 per share.
Technical Analysis of Arrowhead Pharmaceuticals
Should I short Arrowhead Pharmaceuticals stock?
-
ARWR Moving Average Covergence Divergence (MACD) indicator is -0.18, suggesting Arrowhead Pharmaceuticals is a Sell
-
Arrowhead Pharmaceuticals Relative Strength Index (RSI) is 39.36, which suggest Arrowhead Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Arrowhead Pharmaceuticals is (19.09 - 24.35), which suggest Arrowhead Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Arrowhead Pharmaceuticals is (19.24 - 23.9), which suggest Arrowhead Pharmaceuticals is a Sell
* Arrowhead Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.